ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004

FDA News: Agency Accepting Nominations For Patient Representatives

May 8, 1998

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS

July 3, 1987

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003